The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2025
Filed:
Apr. 09, 2021
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Benjamin Matteson Vincent, Cambridge, MA (US);
Daniel Forrest Tardiff, Arlington, MA (US);
Jeff Scott Piotrowski, Somerville, MA (US);
Eric Solis, Milford, MA (US);
Robert Hughie Scannevin, Hopkinton, MA (US);
Chee-Yeun Chung, Brookline, MA (US);
Rebecca Aron, Cambridge, MA (US);
Bertrand Le Bourdonnec, Northborough, MA (US);
Matthew Lucas, Lexington, MA (US);
Kenneth Rhodes, Belmont, MA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 25/14 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 45/06 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 45/06 (2013.01); A61P 25/14 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); G01N 33/6896 (2013.01); G01N 2333/46 (2013.01); G01N 2333/775 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2828 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/285 (2013.01);
Abstract
The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.